001     168383
005     20240229133607.0
024 7 _ |a 10.1158/1055-9965.EPI-20-1726
|2 doi
024 7 _ |a pmid:33849969
|2 pmid
024 7 _ |a 1055-9965
|2 ISSN
024 7 _ |a 1538-7755
|2 ISSN
024 7 _ |a altmetric:103884168
|2 altmetric
037 _ _ |a DKFZ-2021-00870
041 _ _ |a English
082 _ _ |a 610
100 1 _ |a Heath, Alicia K
|0 0000-0001-6517-1300
|b 0
245 _ _ |a Soft drink and juice consumption and renal cell carcinoma incidence and mortality in the European Prospective Investigation into Cancer and Nutrition.
260 _ _ |a Philadelphia, Pa.
|c 2021
|b AACR
336 7 _ |a article
|2 DRIVER
336 7 _ |a Output Types/Journal article
|2 DataCite
336 7 _ |a Journal Article
|b journal
|m journal
|0 PUB:(DE-HGF)16
|s 1625058669_23645
|2 PUB:(DE-HGF)
336 7 _ |a ARTICLE
|2 BibTeX
336 7 _ |a JOURNAL_ARTICLE
|2 ORCID
336 7 _ |a Journal Article
|0 0
|2 EndNote
500 _ _ |a 2021 Jun;30(6):1270-1274
520 _ _ |a Renal cell carcinoma (RCC) accounts for more than 80% of kidney cancers in adults and obesity is a known risk factor. Regular consumption of sweetened beverages has been linked to obesity and several chronic diseases including some types of cancer. It is uncertain whether soft drink and juice consumption is associated with risk of RCC. We investigated the associations of soft drink and juice consumption with RCC incidence and mortality in the European Prospective Investigation into Cancer and Nutrition (EPIC).389,220 EPIC participants with median age 52 years at recruitment (1991-2000) were included. Cox regression yielded adjusted hazard ratios (HRs) and 95% confidence intervals (CIs) for RCC incidence and mortality in relation to intakes of juices and total, sugar-sweetened, and artificially-sweetened soft drinks.888 incident RCCs and 356 RCC deaths were identified. In models including adjustment for body mass index and energy intake, there was no higher risk of incident RCC associated with consumption of juices (HR per 100 g/day increment=1.03, 95% CI 0.97-1.09), total soft drinks (HR=1.01, 0.98-1.05), sugar-sweetened soft drinks (HR=0.99, 0.94-1.05), or artificially-sweetened soft drinks (HR=1.02, 0.96-1.08). In these fully-adjusted models, none of the beverages were associated with RCC mortality (HR, 95% CI per 100 g/day increment 1.06, 0.97-1.16; 1.03, 0.98-1.09; 0.97, 0.89-1.07; and 1.06, 0.99-1.14, respectively).Consumption of juices or soft drinks was not associated with RCC incidence or mortality after adjusting for obesity.Soft drink and juice intakes are unlikely to play an independent role in RCC development or mortality.
536 _ _ |a 313 - Krebsrisikofaktoren und Prävention (POF4-313)
|0 G:(DE-HGF)POF4-313
|c POF4-313
|x 0
|f POF IV
588 _ _ |a Dataset connected to CrossRef, PubMed, , Journals: inrepo01.inet.dkfz-heidelberg.de
700 1 _ |a Clasen, Joanna L
|0 0000-0003-4231-5740
|b 1
700 1 _ |a Jayanth, Nick P
|0 0000-0002-6906-4219
|b 2
700 1 _ |a Jenab, Mazda
|b 3
700 1 _ |a Tjonneland, Anne
|0 0000-0003-4385-2097
|b 4
700 1 _ |a Petersen, Kristina E N
|b 5
700 1 _ |a Overvad, Kim
|b 6
700 1 _ |a Srour, Bernard
|0 P:(DE-He78)0644671d309776d45e0fc705d1156cac
|b 7
|u dkfz
700 1 _ |a Katzke, Verena
|0 P:(DE-He78)fb68a9386399d72d84f7f34cfc6048b4
|b 8
|u dkfz
700 1 _ |a Bergmann, Manuela M
|0 0000-0001-5064-227X
|b 9
700 1 _ |a Schulze, Matthias B
|0 0000-0002-0830-5277
|b 10
700 1 _ |a Masala, Giovanna
|0 0000-0002-5758-9069
|b 11
700 1 _ |a Krogh, Vittorio
|0 0000-0003-0122-8624
|b 12
700 1 _ |a Tumino, Rosario
|0 0000-0003-2666-414X
|b 13
700 1 _ |a Catalano, Alberto
|0 0000-0003-2597-2060
|b 14
700 1 _ |a Pasanisi, Fabrizio
|b 15
700 1 _ |a Brustad, Magritt
|b 16
700 1 _ |a Olsen, Karina Standahl
|0 0000-0002-2539-4603
|b 17
700 1 _ |a Skeie, Guri
|0 0000-0003-2476-4251
|b 18
700 1 _ |a Lujan-Barroso, Leila
|0 0000-0001-6224-1764
|b 19
700 1 _ |a Rodríguez-Barranco, Miguel
|0 0000-0002-9972-9779
|b 20
700 1 _ |a Amiano, Pilar
|b 21
700 1 _ |a Santiuste, Carmen
|b 22
700 1 _ |a Barricarte Gurrea, Aurelio
|b 23
700 1 _ |a Axelson, Håkan
|b 24
700 1 _ |a Ramne, Stina
|0 0000-0003-1291-4494
|b 25
700 1 _ |a Ljungberg, Borje
|0 0000-0002-4121-3753
|b 26
700 1 _ |a Watts, Eleanor L
|0 0000-0001-9229-2589
|b 27
700 1 _ |a Huybrechts, Inge
|0 0000-0003-3838-855X
|b 28
700 1 _ |a Weiderpass, Elisabete
|0 0000-0003-2237-0128
|b 29
700 1 _ |a Riboli, Elio
|b 30
700 1 _ |a Muller, David C
|b 31
773 _ _ |a 10.1158/1055-9965.EPI-20-1726
|g p. cebp.1726.2020 -
|0 PERI:(DE-600)2036781-8
|n 6
|p 1270-1274
|t Cancer epidemiology, biomarkers & prevention
|v 30
|y 2021
|x 1538-7755
909 C O |o oai:inrepo02.dkfz.de:168383
|p VDB
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 7
|6 P:(DE-He78)0644671d309776d45e0fc705d1156cac
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 8
|6 P:(DE-He78)fb68a9386399d72d84f7f34cfc6048b4
913 0 _ |a DE-HGF
|b Gesundheit
|l Krebsforschung
|1 G:(DE-HGF)POF3-310
|0 G:(DE-HGF)POF3-313
|3 G:(DE-HGF)POF3
|2 G:(DE-HGF)POF3-300
|4 G:(DE-HGF)POF
|v Cancer risk factors and prevention
|x 0
913 1 _ |a DE-HGF
|b Gesundheit
|l Krebsforschung
|1 G:(DE-HGF)POF4-310
|0 G:(DE-HGF)POF4-313
|3 G:(DE-HGF)POF4
|2 G:(DE-HGF)POF4-300
|4 G:(DE-HGF)POF
|v Krebsrisikofaktoren und Prävention
|x 0
914 1 _ |y 2021
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0200
|2 StatID
|b SCOPUS
|d 2021-02-02
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0300
|2 StatID
|b Medline
|d 2021-02-02
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0199
|2 StatID
|b Clarivate Analytics Master Journal List
|d 2021-02-02
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1030
|2 StatID
|b Current Contents - Life Sciences
|d 2021-02-02
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0160
|2 StatID
|b Essential Science Indicators
|d 2021-02-02
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1050
|2 StatID
|b BIOSIS Previews
|d 2021-02-02
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1110
|2 StatID
|b Current Contents - Clinical Medicine
|d 2021-02-02
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1190
|2 StatID
|b Biological Abstracts
|d 2021-02-02
915 _ _ |a WoS
|0 StatID:(DE-HGF)0113
|2 StatID
|b Science Citation Index Expanded
|d 2021-02-02
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0150
|2 StatID
|b Web of Science Core Collection
|d 2021-02-02
915 _ _ |a JCR
|0 StatID:(DE-HGF)0100
|2 StatID
|b CANCER EPIDEM BIOMAR : 2019
|d 2021-02-02
915 _ _ |a IF < 5
|0 StatID:(DE-HGF)9900
|2 StatID
|d 2021-02-02
920 1 _ |0 I:(DE-He78)C020-20160331
|k C020
|l C020 Epidemiologie von Krebs
|x 0
980 _ _ |a journal
980 _ _ |a VDB
980 _ _ |a I:(DE-He78)C020-20160331
980 _ _ |a UNRESTRICTED


LibraryCollectionCLSMajorCLSMinorLanguageAuthor
Marc 21